每日特惠-併購

路透中文

07/20

每日特惠-併購

路透7月20日 - 截至周一1000 GMT，已報告以下收購要約、合併、收購和資產處置：

** 英國Segro < SGRO.L (link)> 拒絕了普洛斯（Prologis）< PLD.N (link)> 提出的135億英鎊（182億美元）的更高的收購要約，雙方對峙局面進一步升級，這家美國倉儲巨頭正敦促競爭對手的股東施壓董事會，要求其同意該交易。

nL4N43M0CD

** 韓國三星生物製藥（Samsung Biologics）< 207940.KS (link)> 將對瑞士合同製藥商PolyPeptide< PPGN.S (link)> 發起14.6億瑞士法郎(18.1億美元) 的全現金收購要約，兩家公司在各自發布的聲明中表示。

nL6N43L0AP

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2652904292"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2652904292\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2652904292?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-07-20 18:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2652904292","market":"us","top_or_hot":-1,"title":"每日特惠-併購","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>每日特惠-併購</title></head><body><p><span>路透7月20日</span><span> - </span>截至周一1000 GMT，已報告以下收購要約、合併、收購和資產處置：</p><p>** 英國Segro &lt; SGRO.L (link)&gt; 拒絕了普洛斯（Prologis）&lt; PLD.N (link)&gt; 提出的135億英鎊（182億美元）的更高的收購要約，雙方對峙局面進一步升級，這家美國倉儲巨頭正敦促競爭對手的股東施壓董事會，要求其同意該交易。</p><p><span>nL4N43M0CD</span></p><p>** 韓國三星生物製藥（Samsung Biologics）&lt; 207940.KS (link)&gt; 將對瑞士合同製藥商PolyPeptide&lt; PPGN.S (link)&gt; 發起14.6億瑞士法郎(18.1億美元) 的全現金收購要約，兩家公司在各自發布的聲明中表示。</p><p><span>nL6N43L0AP</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>每日特惠-併購</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n每日特惠-併購\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time smaller\">2026-07-20 18:26</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>每日特惠-併購</title></head><body><p><span>路透7月20日</span><span> - </span>截至周一1000 GMT，已報告以下收購要約、合併、收購和資產處置：</p><p>** 英國Segro &lt; SGRO.L (link)&gt; 拒絕了普洛斯（Prologis）&lt; PLD.N (link)&gt; 提出的135億英鎊（182億美元）的更高的收購要約，雙方對峙局面進一步升級，這家美國倉儲巨頭正敦促競爭對手的股東施壓董事會，要求其同意該交易。</p><p><span>nL4N43M0CD</span></p><p>** 韓國三星生物製藥（Samsung Biologics）&lt; 207940.KS (link)&gt; 將對瑞士合同製藥商PolyPeptide&lt; PPGN.S (link)&gt; 發起14.6億瑞士法郎(18.1億美元) 的全現金收購要約，兩家公司在各自發布的聲明中表示。</p><p><span>nL6N43L0AP</span></p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GQRE","symbol_name":"FlexShares Global Quality Real E","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nL4S43M0MF:1","article_id":"2652904292","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2652904292","pubTimestamp":1784543169,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"每日特惠-併購路透7月20日-截至周一1000 GMT，已報告以下收購要約、合併、收購和資產處置：** 英國Segro < SGRO.L > 拒絕了普洛斯< PLD.N > 提出的135億英鎊的更高的收購要約，雙方對峙局面進一步升級，這家美國倉儲巨頭正敦促競爭對手的股東施壓董事會，要求其同意該交易。nL4N43M0CD** 韓國三星生物製藥< 207940.KS > 將對瑞士合同製藥商PolyPeptide< PPGN.S > 發起14.6億瑞士法郎 的全現金收購要約，兩家公司在各自發布的聲明中表示。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"GQRE":"FlexShares Global Quality Real E","FRI":"不动产投资信托指数ETF-First Trust S&P","RWO":"全球房地产ETF-SPDR","BK5114":"工业房地产投资信托","SPRE":"SP Funds S&P Global REIT Sharia ETF","RWR":"SPDR DJ Wilshire REIT ETF","BBRE":"JPMorgan BetaBuilders MSCI US REIT ETF","DTRE":"First Trust Alerian Disruptive Technology Real Estate ETF","USRT":"iShares Core U.S. REIT ETF","CRED":"COLUMBIA RESEARCH ENHANCED REAL ESTATE ETF","DFGR":"DIMENSIONAL GLOBAL REAL ESTATE ETF","URE":"两倍做多房地产ETF-ProShares","SGRO.UK":"SEGRO","IYR":"房地产指数ETF-iShares道琼斯","PLD":"安博","REET":"iShares Trust iShares Global REIT ETF","PPTY":"U.S. Diversified Real Estate ETF","IYRI":"NEOS Real Estate High Income ETF","JPRE":"JPMorgan Realty Income ETF","PSR":"Invesco Active U.S. Real Estate ETF","JRE":"Janus Henderson U.S. Real Estate ETF","VGSR":"VERT GLOBAL SUSTAINABLE REAL ESTATE ETF","BK4588":"碎股","ICF":"不动产指数ETF-iShares","ERET":"ISHARES ENVIRONMENTALLY AWARE REAL ESTATE ETF","XLRE":"Real Estate Select Sector SPDR Fund","WTRE":"WisdomTree New Economy Real Estate Fund","SCHH":"Schwab U.S. REIT ETF","REIT":"ALPS Active REIT ETF","BK4171":"工业房地产投资信托","AVRE":"Avantis Real Estate ETF","INDS":"PACER INDUSTRIAL REAL ESTATE ETF","VNQ":"不动产信托指数ETF-Vanguard","RITA":"ETFB GREEN SRI REITS ETF","FREL":"Fidelity MSCI Real Estate Index ETF","BK4567":"ESG概念","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","DFAR":"Dimensional US Real Estate ETF","BK4224":"工业房地产信托"},"translate_title":"Special of the Day-Mergers and Acquisitions","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VNQ":0.6,"SPRE":0.6,"PLD":0.9,"USRT":0.6,"URE":0.6,"AVRE":0.6,"IYRI":0.6,"RWR":0.6,"PSR":0.6,"REET":0.6,"RITA":0.6,"ERET":0.6,"PPTY":0.6,"XLRE":0.6,"DFAR":0.6,"FRI":0.6,"WTRE":0.6,"ICF":0.6,"SCHH":0.6,"VGSR":0.6,"CRED":0.6,"BBRE":0.6,"DFGR":0.6,"IYR":0.6,"RWO":0.6,"INDS":0.6,"GQRE":0.6,"FREL":0.6,"SGRO.UK":0.9,"JPRE":0.6,"REIT":0.6,"JRE":0.6,"DTRE":0.6},"content_text":"每日特惠-併購路透7月20日 - 截至周一1000 GMT，已報告以下收購要約、合併、收購和資產處置：** 英國Segro < SGRO.L (link)> 拒絕了普洛斯（Prologis）< PLD.N (link)> 提出的135億英鎊（182億美元）的更高的收購要約，雙方對峙局面進一步升級，這家美國倉儲巨頭正敦促競爭對手的股東施壓董事會，要求其同意該交易。nL4N43M0CD** 韓國三星生物製藥（Samsung Biologics）< 207940.KS (link)> 將對瑞士合同製藥商PolyPeptide< PPGN.S (link)> 發起14.6億瑞士法郎(18.1億美元) 的全現金收購要約，兩家公司在各自發布的聲明中表示。nL6N43L0AP","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}